Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Ametek (AME)

AMETEK Reports Record Q1 Sales of $1.74 Billion and Raises 2024 Adjusted EPS Guidance

Positive Impact 4 of 5 earnings Written later

AMETEK reported first-quarter 2024 sales of $1.74 billion, up 9% from a year earlier, and adjusted earnings of $1.64 per diluted share, up 10%. The company raised its 2024 adjusted earnings per share guidance to $6.74 to $6.86 from $6.70 to $6.85, which benefits shareholders if the outlook holds.

Key points

  • First-quarter sales of $1.74 billion, up 9% from the first quarter of 2023
  • GAAP diluted EPS of $1.34 versus $1.32 a year earlier; adjusted EPS of $1.64 versus $1.49
  • 2024 adjusted EPS guidance raised to $6.74 to $6.86 from $6.70 to $6.85
  • Paragon Medical integration costs of $29.2 million pre-tax weighed on GAAP results

The filing

CompanyAmetek (AME)
Form8-K, current report
Filed with the SECMay 2, 2024, 10:26 AM ET
Accession number0001037868-24-000028

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 02, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.